In HFFD male Slc39a5-/- mice, however, there were no improvements in serum ALT, AST, and NAFLD activity score (Figure 4—figure supplement 1I–K), despite reductions in hepatic triglyceride content (Figure 4—figure supplement 1H). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.